Výsledky vyhledávání - "Zudaire Ripa MT"

Treatment of steroid-refractory chronic graft-versus-host disease with imatinib: Real-life experience of the Spanish group of hematopoietic transplantation (GETH)

Autor: Parra Salinas I, Bermudez A, López Corral L, Lopez Godino O, Móles-Poveda P, Martín G, Costilla Barriga L, Ferrá Coll C, Márquez-Malaver F, Ortí G, Zudaire Ripa MT, Rifon J, Martinez C

Publikováno v: CLINICAL TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Treatment of steroid-refractory chronic graft-versus-host disease (cGVHD) is a challenge. Here, we describe a retrospective analysis of 66 patients with steroid-refractory cGVHD treated with imatinib (starting dose of 100 mg in 70% of patients; maxim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::2d07a7ecdbff06e92bbe58f12b9653e8
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13871

Zobrazit plný text záznamu

Akademický článek

Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.

Autor: Escamilla Gómez V; Department of Hematology of the University Hospital Virgen del Rocío, Instituto de Biomedicina (IBIS/CSIC/CIBERONC, CB16/12/00480), Universidad de Sevilla, Seville, Spain., García-Gutiérrez V; Department of Hematology, University Hospital Ramon y Cajal, IRYCIS, Madrid, Spain. jvalentingg@gmail.com., López Corral L; Complejo Asistencial Universitario de Salamanca-IBSAL, Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain., García Cadenas I; Hospital Santa Creu I Sant Pau, Barcelona, Spain., Pérez Martínez A; Clinic University Hospital of Valencia, Valencia, Spain., Márquez Malaver FJ; Department of Hematology of the University Hospital Virgen del Rocío, Instituto de Biomedicina (IBIS/CSIC/CIBERONC, CB16/12/00480), Universidad de Sevilla, Seville, Spain., Caballero-Velázquez T; Department of Hematology of the University Hospital Virgen del Rocío, Instituto de Biomedicina (IBIS/CSIC/CIBERONC, CB16/12/00480), Universidad de Sevilla, Seville, Spain., González Sierra PA; University Hospital, Granada, Spain., Viguria Alegría MC; Hospital of Navarra, Navarra, Spain., Parra Salinas IM; University Hospital Miguel Servet, Zaragoza, Spain., Calderón Cabrera C; Department of Hematology of the University Hospital Virgen del Rocío, Instituto de Biomedicina (IBIS/CSIC/CIBERONC, CB16/12/00480), Universidad de Sevilla, Seville, Spain., González Vicent M; Hospital Niño Jesús, Madrid, Spain., Rodríguez Torres N; Department of Hematology of the University Hospital Virgen del Rocío, Instituto de Biomedicina (IBIS/CSIC/CIBERONC, CB16/12/00480), Universidad de Sevilla, Seville, Spain., Parody Porras R; Instituto Catalá de Oncología Hospitalet, Barcelona, Spain., Ferra Coll C; Instituto Catalá de Oncología Germans Trias, Badalona, Spain., Orti G; University Hospital Vall d´Hebron, Barcelona, Spain., Valcárcel Ferreiras D; University Hospital Vall d´Hebron, Barcelona, Spain., De la Cámara LLanzá R; Hospital La Princesa, Madrid, Spain., Molés P; Hospital La Fe, Valencia, Spain., Velázquez-Kennedy K; Department of Hematology, University Hospital Ramon y Cajal, IRYCIS, Madrid, Spain., João Mende M; Complejo Asistencial Universitario de Salamanca-IBSAL, Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain., Caballero Barrigón D; Complejo Asistencial Universitario de Salamanca-IBSAL, Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain., Pérez E; Complejo Asistencial Universitario de Salamanca-IBSAL, Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain., Martino Bofarull R; Hospital Santa Creu I Sant Pau, Barcelona, Spain., Saavedra Gerosa S; Hospital Santa Creu I Sant Pau, Barcelona, Spain., Sierra J; Hospital Santa Creu I Sant Pau, Barcelona, Spain., Poch M; Clinic University Hospital of Valencia, Valencia, Spain., Zudaire Ripa MT; Hospital of Navarra, Navarra, Spain., Díaz Pérez MA; Hospital Niño Jesús, Madrid, Spain., Molina Angulo B; Hospital Niño Jesús, Madrid, Spain., Sánchez Ortega I; Instituto Catalá de Oncología Hospitalet, Barcelona, Spain., Sanz Caballer J; Hospital La Fe, Valencia, Spain., Montoro Gómez J; Hospital La Fe, Valencia, Spain., Espigado Tocino I; Department of Hematology of the University Hospital Virgen del Rocío, Instituto de Biomedicina (IBIS/CSIC/CIBERONC, CB16/12/00480), Universidad de Sevilla, Seville, Spain., Pérez-Simón JA; Department of Hematology of the University Hospital Virgen del Rocío, Instituto de Biomedicina (IBIS/CSIC/CIBERONC, CB16/12/00480), Universidad de Sevilla, Seville, Spain. josea.perez.simon.sspa@juntadeandalucia.es.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2020 Mar; Vol. 55 (3), pp. 641-648. Date of Electronic Publication: 2019 Nov 07.